Biopharma Gains Ground On ACA Formularies
This article was originally published in RPM Report
Executive Summary
CMS’ final rule on Benefit and Payment Parameters for the Affordable Care Act health exchange plans includes new formulary provisions that move a bit closer to the protections on access included in Medicare Part D. Now if only industry could get rid of specialty-tier-only classes.